[Facts and myths about chronic fatigue syndrome].
Fink, Per, Skjernov, Mathias, Petersen, Line Kirkeby et al. · Ugeskrift for laeger · 2022
Quick Summary
This article discusses updates to ME/CFS treatment guidelines and challenges some common beliefs about the condition. The authors argue that new guidelines recommend against intense exercise programs for severely ill patients and suggest energy management instead, but they question whether the evidence supporting these changes was properly evaluated. They raise concerns about how the new guidelines were developed and what type of evidence was considered.
Why It Matters
This critique is important because it directly addresses how ME/CFS treatment guidelines are developed and what evidence is prioritized. The concerns about methodology and bias in guideline development have implications for which treatments patients may have access to and how healthcare providers approach ME/CFS management.
Observed Findings
- NICE guidelines recommend against graded exercise therapy for severely ill ME/CFS patients
- Cognitive behavioral therapy is recommended only for managing consequences of ME/CFS, not the condition itself
- New NICE guidelines recommend energy management as a primary approach
- The authors argue the guideline committee dismissed evidence from studies not using new diagnostic criteria
- The authors question whether patient viewpoints were appropriately integrated into guideline development
Inferred Conclusions
- The authors conclude that the new NICE guidelines were developed using a consensus-driven approach rather than rigorous evidence evaluation
- They infer that bias may have influenced which evidence and perspectives were considered
- The authors suggest that energy management should be prioritized over graded exercise for severely ill patients
- They argue that the guideline development process may have excluded important existing evidence
Remaining Questions
- What specific evidence was excluded from NICE guideline review and why?
- How should evidence quality be weighted when some studies use older diagnostic criteria?
- What is the optimal approach to energy management for ME/CFS patients at different severity levels?
- How can guideline development processes better balance scientific evidence with patient and expert perspectives?
What This Study Does Not Prove
This editorial does not present new clinical trial data or original research findings. It does not prove that the NICE guidelines are incorrect, nor does it establish the efficacy of any specific treatment. It is a commentary expressing expert disagreement with guideline methodology rather than definitive evidence about what treatments work best for ME/CFS.
Topics
Tags
Metadata
- PMID
- 35656619
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 7 April 2026